Statistics for Lantern Pharma (id:5797 LTRN)

Valuation metrics

Market cap

31.81M

Enterprise value

3.77M

Trailing P/E (ttm)

-2.10

Forward P/E

-1.46

PEG ratio

-1.46

Price/Sales (ttm)

Price/Book (mrq)

0.77

Enterprise Value/Revenue

Enterprise Value/EBITDA

-0.19

Overview

Shares outstanding

10.78M

Float

7.94M

Shares short

176.91K

% Held by insiders

0.15%

% Held by institutions

0.24%

Average volume (10 days)

62.32K

Average volume (90 days)

Price summary

52-Week low

2.79

52-Week high

11.99

52-Week change

-30.91%

Beta

1.57

50-Day moving average

3.57

200-Day moving average

4.96

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-28.07%

Return on equity

-44.82%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-19,525,462.00

Net income to common (ttm)

-17,747,688.00

Diluted EPS (ttm)

-1.78

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

33.26M

Total cash per share (mrq)

3.09

Total debt (mrq)

218.70K

Total Debt/Equity (mrq)

0.71

Current ratio (mrq)

767.10%

Book value per share (mrq)

3.82

Cash flow

Cash flow statement

-15,256,622.00

Levered free cash flow (LFCF)

-8,713,126.00